CHRISTIN WILKINS: Open Payments
NPI 1831565357 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 35 payments from 13 companies in 2025. Trend: 2023 $5,281 · 2024 $905 · 2025 $1,701
Food & beverage: $880Travel & lodging: $821
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 15 | $1,305 |
| PFIZER INC. | 4 | $81 |
| Novo Nordisk Inc | 4 | $79 |
| Alnylam Pharmaceuticals Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Recor Medical Inc | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
Products named: SYMPLICITY G3, Wegovy, ELIQUIS, AMVUTTRA, VYNDAQEL, LEQVIO, COREVALVE EVOLUT R, VERQUVO.
Industry payments across TX — which companies pay providers there.
